Pharmaceutical industry developments : specialty drugs, coupons, reverse payments and product hopping

Specialty drugs: background and policy concerns.
Prescription drug discount couons: implications for public and commercial health care plans.
Manufacturer safeguards may not prevent copayment coupon use for part D drugs.
Pharmaceutical patent-antitrust: reverse payment settlements and product hopping.